Business · Companies · 1 day ago
Investors expect BASF to renew its bid for Evonik
BASF is expected to make another offer for Evonik in the coming weeks, according to investors and shareholder representatives.
Evonik's board rejected BASF's first takeover offer, and the German chemicals companies are now at the center of a possible renewed bid.
BASF is Germany's largest chemicals company.
Investors expect a new offer to be worth about €25 per Evonik share.
That figure is an expectation, not a confirmed offer.
BASF could raise its bid, but the sources do not say whether it will or when a decision will be made.
Evonik’s board rejected BASF’s first takeover offer.
BASF may raise its bid, according to the FAZ.
Investors and shareholder representatives expect BASF to make another approach in the coming weeks.
They expect a purchase price of around 25 euros per Evonik share.
- Who
- BASF and Evonik.
- What
- BASF made a takeover offer for Evonik, which Evonik’s board rejected. BASF may increase the offer.
- When
- The articles were published on October 13, 2026; investors expect a new approach in the coming weeks.
- Where
- Not stated.
- Why
- BASF is seeking to acquire Evonik; the reason for the proposed takeover is not stated.
BASF
Evonik’s board
Offer
BASF
BASF made a takeover offer for Evonik.
Evonik’s board
The board rejected BASF’s first offer.
Possible next step
BASF
BASF may raise its offer.
Evonik’s board
Not stated
Evonik’s board rejected BASF’s first takeover offer.
Investors and shareholder representatives said they expected BASF to make a new approach in the coming weeks.
- First offer
- Rejected by Evonik’s board
- Expected next approach
- In the coming weeks
- Expected price
- Around 25 euros per Evonik share
- Investor representative
- Ulrich Hocker, DSW president
2 sources
What people are saying
I am convinced that BASF will now see this through